Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 19,372 shares at $47.40 ($928K) on 2025-03-19, disclosed to the SEC on 2025-03-20.
Open-market sale of $928k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 3,341 | $155K | 16.7% |
| 2 | $46.29 | 3,341 | $155K | 16.7% |
| 3 | $47.40 | 3,261 | $155K | 16.7% |
| 4 | $47.40 | 3,261 | $155K | 16.7% |
| 5 | $50.11 | 3,084 | $155K | 16.7% |
| 6 | $50.11 | 3,084 |
| $155K |
| 16.7% |
| Total | $47.88 avg | 19,372 | $928K | 100% |
| Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |
| TARS | SELL | 2023-03-21 | $9K | — | Filing → |